THE MINIMED™ 670G HYBRID AUTOMATED INSULIN DELIVERY SYSTEM: SETTING THE RIGHT EXPECTATIONS

被引：4
|
作者：
Leelarathna, Lalantha
Thabit, Hood
机构：
[1] Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Diabet Ctr, Manchester, Lancs, England
[2] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Fac Biol Med & Hlth, Manchester, Lancs, England
来源：
ENDOCRINE PRACTICE | 2018年 / 24卷 / 07期
关键词：
EXPERIENCE; ADULTS;
D O I：
10.4158/EP-2018-0242
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：698 / 700
页数：3
相关论文
共 50 条
  • [21] Minimed 640G vs. Minimed 670G, a Comparison in Children and Adolescents with Diabetes Type 1
    Scaramuzza, Andrea E.
    Rabbone, Ivana
    Bonfanti, Riccardo
    DIABETES, 2019, 68
  • [22] UNANNOUNCED MEAL CHALLENGES IN A PROTECTED FREE LIVING ENVIRONMENT USING THE MINIMED 670G 4.0 SYSTEM
    Tirosh, A.
    Cohen, O.
    Shalit, R.
    Laron-Hirsh, M.
    Kurtz, N.
    Roy, A.
    Grosman, B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A102 - A103
  • [23] Clinical Experience with the MiniMed 670G System in Children, Adolescents, and Young Adults with Type 1 Diabetes
    Henson, Carlo J.
    Barnes, Timothy L.
    Nickel, Amanda J.
    Abuzzahab, M. Jennifer
    Kyllo, Jennifer
    Gandrud, Laura M.
    DIABETES, 2018, 67
  • [24] Glycaemic outcomes in subjects with and without prior CGM experience, in the MiniMed™ 670G system pivotal trial
    Lee, S. W.
    Garg, S. K.
    Bode, B. W.
    Ilany, J.
    Weinzimer, S. A.
    Brazg, R.
    Bailey, T. S.
    Bergenstal, R. M.
    Buckingham, B. A.
    Slover, R. H.
    Anderson, S. M.
    Shin, J.
    Chen, X.
    Cordero, T. L.
    Kaufman, F. R.
    DIABETOLOGIA, 2017, 60 : S327 - S327
  • [25] GLYCEMIC OUTCOMES DURING MINIMED™ 670G SYSTEM USE IN CHILDREN WITH T1D
    Buckingham, B.
    Shulman, D.
    Forlenza, G.
    Bode, B.
    Pinhas-Hamiel, O.
    Wood, M.
    Kaiserman, K.
    Liljenquist, D.
    Bailey, T.
    Shin, J.
    Huang, S.
    Cordero, T.
    Lee, S.
    Kaufman, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A19 - A19
  • [26] 1-YEAR SUSTAINABILITY OF THE MINIMED™ 670G SYSTEM OUTCOMES IN REAL-WORLD CONDITIONS
    Da Silva, J.
    Arrieta, A.
    Castaneda, J.
    Cohen, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A74 - A74
  • [27] Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes
    Jendle, Johan
    Pohlmann, Johannes
    de Portu, Simona
    Smith-Palmer, Jayne
    Roze, Stephane
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (03) : 110 - 118
  • [28] REAL-WORLD ASSESSMENT OF FORMER MDI PATIENTS' EXPERIENCE ON THE MEDTRONIC MINIMED™ 670G HYBRID CLOSED-LOOP SYSTEM
    Gopalakrishnan, S.
    Mueckler, J.
    Jinghua, C.
    Jordin, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A85 - A86
  • [29] Glucose control during Ramadan fasting in a teenager with type 1 diabetes on MiniMed 670G hybrid closed-loop system
    Petrovski, Goran
    Al Khalaf, Fawziya
    Campbell, Judith
    Hussain, Khalid
    Fisher, Hannah
    Umer, Fareeda
    ACTA DIABETOLOGICA, 2020, 57 (01) : 105 - 107
  • [30] Analysis of the MiniMed 670G Pivotal Trial Data Using Novel Composite Metrics
    Vigersky, Robert A.
    Thomas, Andreas
    Shin, John
    Jiang, Boyi
    McMahon, Chantal
    DIABETES, 2017, 66 : A276 - A276
12345